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Abstract
Background: Cytoplasmic dynein and its regulatory proteins have been implicated in neuronal and non-neuronal
cell migration. A genetic model for analyzing the role of cytoplasmic dynein specifically in these processes has,
however, been lacking. The Loa (Legs at odd angles) mouse with a mutation in the dynein heavy chain has been
the focus of an increasing number of studies for its role in neuron degeneration. Despite the location of this
mutation in the tail domain of the dynein heavy chain, we previously found a striking effect on coordination
between the two dynein motor domains, resulting in a defect in dynein run length in vitro and in vivo.
Results: We have now tested for effects of the Loa mutation on neuronal migration in the developing neocortex.
Loa homozygotes showed clear defects in neocortical lamination and neuronal migration resulting from a
reduction in the rate of radial migration of bipolar neurons.
Conclusions: These results present a new genetic model for understanding the dynein pathway and its functions
during neuronal migration. They also provide the first evidence for a link between dynein processivity and somal
movement, which is essential for proper development of the brain.
Background
Cytoplasmic dynein is a minus-end directed microtubule
motor protein involved in a wide variety of functions. In
order to perform such diverse activities in the cell,
dynein makes use of numerous regulatory partners,
including dynactin, LIS1, NudE and NudEL [1-3]. LIS1
and NudE/L, in particular, have received considerable
attention for their role in brain development [4-7].
Sporadic mutations in LIS1 cause type I, or classical, lis-
sencephaly, a severe brain developmental disease charac-
terized by a smooth cortical surface [8]. Patients with
lissencephaly exhibit lamination defects of the cerebral
cortex, consistent with a defect in neuronal migration.
Developmental analysis of LIS1 mutant mouse lines has
shown that a reduction of LIS1 protein leads to neocor-
tical organization defects in a dose-dependent manner
[5,9-11]. Live analysis of embryonic rat brain subjected
to LIS1 RNA interference (RNAi) has directly demon-
strated defects in neural progenitor cell division, radial
migration, and axon elongation [7,12]. The genes
encoding NudE and NudEL, Nde1 and Ndel1, are clo-
sely related and interact genetically with LIS1 and cyto-
plasmic dynein [13]. Nde1 and Ndel1 mutant mice
exhibit either microcephalic or lissencephalic brain phe-
notypes, consistent with a functional relationship to
LIS1 [6,14-16].
Several studies have focused on the role of genes in the
dynein pathway in mammalian brain development. How-
ever, there are no genetic models with which to study the
involvement of dynein directly. Mice homozygous null
for the cytoplasmic dynein heavy chain gene exhibit early
embryonic lethality, whereas heterozygotes show no
obvious abnormalities [17]. However, several dynein
mutant mouse strains have since been identified in
screens for genes involved in neurodegeneration [18,19].
Of these dynein mutants, the Loa mutation has received
particular attention [20,21]. The Loa heterozygous mice
are viable and develop early onset neurodegenerative dis-
ease, but the homozygous animals die perinatally due to
an inability to feed [18]. Interestingly, both the Loa/+ and
the Loa/Loa mice exhibited defects in retrograde axonal
transport [18,22]. The Loa mutation resides in the
amino-terminal tail region of the dynein heavy chain.
Nonetheless, enzymatic, biochemical, and single molecule
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Loa mutant dynein due to a disruption in the coordina-
tion of its two motor domains [23]. This defect was man-
ifested as a decrease in processivity for purified mutant
dynein in in vitro single molecule assays. Particle tracking
of lysosome/late endosome transport in cultured wild-
type and Loa hippocampal neurons revealed a marked
reduction in vesicular run lengths that could be
accounted for quantitatively by the reduced processivity
of the mutant dynein [23].
The Loa mouse represents an important model for the
study of neurodegeneration. It should also, in principle,
be useful in evaluating the role of dynein in other func-
tions, such as neuronal migration. In view of its particu-
lar effects on dynein mechanochemical behavior, Loa
also affords an opportunity to test whether dynein pro-
cessivity contributes to this process. The Loa/Loa mice
have been reported to display abnormal facial motor
neuron organization, suggesting potential cellular migra-
tion defects [18]. We report direct evidence that the Loa
mutation disrupts this process, causing a delay in neo-
cortical development, a result that confirms a more gen-
eral value for this mutant mouse strain and has
implications for the role of motor processivity in neuro-
nal migration.
Results
Lamination defects in homozygous Loa mutant mice
To test whether the Loa mutation affects brain develop-
ment, we first examined the lamination pattern of the
cerebral cortex in postnatal day zero (P0) mouse pups.
Wild-type and Loa/Loa brains had a similar cortical
thickness: 1,198 ± 150 μm for wild type versus 1,220 ±
160 μm for Loa/Loa (P = 0.8705; n = 3 brains per geno-
type). Six distinct layers could be identified by DAPI
staining in both wild-type and Loa/+ brains; however,
the boundaries were blurred in the Loa/Loa brains,
especially between neuronal layers III and IV (Figure
1A). To identify individual layers, we measured the den-
sity of Ctip2 and Foxp2 staining, which serve as markers
for layers III and VI, respectively. In the Loa/Loa brains,
Ctip2-positive cells were spread over an area roughly
twice as broad as the compact layer observed in the
wild-type brain (Figure 1B; P < 0.005; n = 3 brains per
genotype). In contrast, there were fewer Foxp2-positive
cells in layer VI of the Loa/Loa brain compared with
wild type (Figure 1C; P < 0.005; n = 3 brains per geno-
type), a further indication of cortical disorganization.
We also examined the hippocampus of the Loa/Loa
mutant brain and noticed that, although overall struc-
ture was normal, the dentate gyrus was smaller than in
t h ew i l d - t y p eb r a i n( F i g u r e2 A ) .W et h e r e f o r ea n a l y z e d
the subset of granule neurons (labeled by Prox-1) that
are born in the subventricular zone of the neocortex
and migrate to form the dentate gyrus [24]. In the Loa/
Loa hippocampus, granule cell redistribution to the den-
tate gyrus was delayed at all time-points examined, and
by P0 the dentate gyrus was smaller and more compact
than in the wild-type hippocampus (Figure 2B).
Together our data revealed lamination defects in both
the neocortical and hippocampal regions of the Loa/Loa
mouse that were similar to, though less severe than,
those reported in the LIS1 compound heterozygous
mutant mice [9,10].
Loa/Loa brains exhibit defects in neuronal migration
To explore the origin of the lamination abnormalities,
we first performed a BrdU birthdating study by injection
of pregnant Loa/+ mice with the thymidine analog 5-
bromo-2’-deoxyuridine (BrdU) at either embryonic day
(E) 16 or 18. BrdU is incorporated into the DNA of S-
phase progenitor cells and serves as a stable marker for
cells born around the time of injection. Brains from
pups exposed to the label at E16 or E18 were analyzed
for the distribution of BrdU-positive cells at P0. In wild-
type brains, E16 BrdU-labeled cells formed a compact
layer near the pial surface by P0 (Figure 3A). In the
Loa/Loa brains, the majority of BrdU-positive cells
migrated to the same cortical region of the brain, but
formed a broader layer and showed many trailing neu-
rons (Figure 3A; P < 0.005 for cell density within the
first two cortical layers; n = 3 brains per genotype). A
similar effect was observed with neurons labeled with
BrdU at E18: the neurons showed a reduced migration
distance, as well as a more scattered distribution in the
Loa/Loa mutants relative to wild-type controls (Figure
3B; P < 0.001 for cell density within the first two cortical
layers; n = 3 brains per genotype).
We also introduced GFP cDNA into neural progeni-
tor cells in the mouse neocortex by in utero electro-
poration at E15 [25]. GFP-positive cells in the
ventricular zone/subventricular zone, intermediate
zone (IZ), and cortical plate (CP) were examined 3, 4,
or 5 days later (Figure 4; n = 3 brains per genotype,
per time-point). In the wild-type brains, 27% of the
transfected neurons had reached the CP by day 3
(E18), and 57.5% by day 4 (Figure 4A,C), a time-course
consistent with previous observations [26,27]. In Loa/
Loa brains, however, the majority of transfected cells
remained within the ventricular zone and subventricu-
lar zone at both day 3 and day 4, with only a subset
having reached the IZ (Figure 4B,C; 45% by day 4; P <
0.01). However, by day 5, the distribution of GFP-posi-
tive cells in Loa/Loa brains was almost identical to
that at day 3 in the wild-type brains (Figure 4B,C; 22%
in the CP of Loa/Loa brains). Thus, the Loa mutation
delays the radial redistribution to the CP by approxi-
mately 2 days in the mouse neocortex.
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Page 2 of 13Figure 1 Cortical defects are apparent in the brains of Loa/Loa animals, but not in the brains of Loa/+ or wild-type mice. (A) Brain
sections stained with DAPI reveal six distinct layers, labeled I to VI, in wild-type and Loa/+ brains, but blurred layer boundaries in the Loa/Loa
brains. Scale bar = 200 μm. (B) Wild-type and Loa/Loa brain slices stained with Ctip2, which labels neurons in layers II/III. Brain sections were
divided into six equal regions and the corresponding graph shows the mean Ctip2 density within each of these regions for each genotype. Error
bars represent the standard deviation. Scale bar = 200 μm. (C) Wild-type and Loa/Loa brain slices stained with Foxp2, which labels neurons in
layer VI. Brain sections were divided into six equal regions and the corresponding graph shows the mean Foxp2 density within each of these
regions for each genotype. Error bars represent the standard deviation. Scale bar = 200 μm.
Ori-McKenney and Vallee Neural Development 2011, 6:26
http://www.neuraldevelopment.com/content/6/1/26
Page 3 of 13Live cell imaging reveals a decreased rate of somal
translocation
To obtain further insight into the basis for the delay in
neuronal redistribution, we performed live cell imaging
of E16 wild-type and Loa/Loa brain slices labeled with
Oregon Green BAPTA AM. Labeled cells within the IZ
exhibited the normal bipolar morphology of radially
migrating neurons. The rates of neuronal movement
towards the pial surface varied with time and from cell
to cell as previously reported [12,28,29] (Figure 5). The
tip of the leading process progressed at a similar average
rate for both wild-type and Loa/Loa neurons (0.16 ±
0.10 μm/minute and 0.17 ± 0.11 μm/minute, respec-
tively; P = 0.817). However, the rate of somal transloca-
tion was significantly different between genotypes, with
an average rate of 0.38 ± .09 μm/minute for wild-type
neurons, but only 0.23 ± 0.6 μm/minute for Loa/Loa
neurons (Figure 5A-C; P < 0.0001; n = 12 cells from at
least three brains per genotype followed for at least 110
minutes).
Many cell bodies of the migrating wild-type and Loa/
Loa neurons were distorted into an elongated shape
during migration. However, the wild-type cell bodies
remained in this stretched conformation for 20.0 ± 11.5
minutes before returning to their normal rounded mor-
phology after advancing, whereas Loa/Loa cell bodies
remained in the stretched state for 38.0 ± 13.0 minutes
(Figure 5A,B; P < 0.05; n = 12). These results are indica-
tive of a prolonged somal translocation state due to the
reduced transport by the Loa mutant motors.
Changes in mitotic progression are not detected in Loa
progenitors
Cytoplasmic dynein is involved in numerous aspects of
mitosis, including mitotic spindle organization and
orientation, interactions of kinetochores with microtu-
bules, and mitotic checkpoint regulation [30-34]. To test
for accumulation of dynein mutant cells in mitosis, we
stained wild-type and Loa/Loa E16 brain slices with an
antibody to phospho-histone 3 (PH3). Although we did
f i n das l i g h ti n c r e a s ei nt he number of PH3-positive
Figure 2 Loa mutant mouse brains exhibit a delay in
hippocampal radial migration. (A) P0 brain slices stained with
DAPI reveal a normal hippocampal structure, but a smaller dentate
gyrus in the Loa/Loa compared with wild-type brains. (B) Embryonic
day (E) 16, E18 and P0 brains were stained with Prox-1, a marker for
granule neurons that migrate to form the dentate gyrus of the
hippocampus. The progression of Prox-1-labeled neurons is delayed
in the Loa/Loa brain compared with the wild-type brain. Scale bars
= 200 μm.
Figure 3 BrdU birthdating study reveals defects in neuronal
migration in the Loa/Loa mutants. (A,B) Pregnant mice were
injected with BrdU at either E16 (A) or E18 (B), and wild-type and
Loa/Loa littermates were sacrificed at P0. (A) Migration of E16 BrdU-
labeled neurons in wild-type and Loa/Loa brain slices reveals a
delay in migration for the Loa/Loa neurons, which is quantified in
the graph below (mean density of BrdU-positive cells ± standard
deviation). (B) Migration of E18 BrdU-labeled neurons in wild-type
and Loa/Loa brain slices reveals a delay in migration for the Loa/Loa
neurons, which is quantified in the graph below (mean density of
BrdU-positive cells ± standard deviation). Scale bar = 200 μm.
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Page 4 of 13Figure 4 In utero electroporation assay exposes a two-day migratory delay in the Loa/Loa mice. (A,B) Coronal sections of a wild-type (A)
or Loa/Loa (B) mouse brain 3, 4, or 5 days after electroporation at E15 with GFP cDNA. In the wild-type brain (A), GFP-positive neurons migrated
radially from the ventricular zone (VZ) to cortical plate (CP) with increasing time, while in the Loa/Loa brain (B), GFP-positive neurons migrated
more slowly and did not reach the CP until day 5. Scale bar = 100 μm. (C) Percentage of GFP-positive cells in different regions of the neocortex
in wild-type and Loa/Loa brains. Error bars represent the standard deviation. At least three mutant brains and three littermate control brains
were analyzed at each day after electroporation. CP, cortical plate; IZ, intermediate zone; SVZ, subventricular zone; VZ, ventricular zone.
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Page 5 of 13cells in the Loa/Loa brain slices compared with wild
type, this difference was not statistically significant (Fig-
ure 6A; P =0 . 0 5 4 ;n=5b r a i ns l i c e sp e rg e n o t y p e ) .
Similarly, counts of PH3-positive cells located in the
ventricular or abventricular (>100 μmf r o mt h ev e n t r i -
cle) regions were not significantly different between
wild-type and Loa/Loa brains (Figure 6A; P = 0.068; n =
5 brain slices per genotype). As an additional test for
impaired cell cycle progression, we performed a 2-hour
BrdU pulse in E16 mice and found a similar number of
BrdU-positive cells in wild-type versus mutant brain
( F i g u r e6 B ) .W ea l s oo b s e r v e d a comparable fraction of
Pax6-positive cells between wild-type and Loa/Loa
brains at both E16 and E18 (data not shown). Wild-type
and Loa/Loa brains are of comparable size and have a
similar cortical thickness (Figure 1); thus, together, these
results argue against the gross mitotic defects that have
been reported for a NudE null mouse [6].
Figure 5 Live cell imaging of radial migration in the intermediate zone. Mouse brains were sectioned and incubated with Oregon Green
BAPTA-1 488 AM, and the labeled bipolar cells were imaged within the IZ. (A) Kymographs of somal translocation within the neurons of the
wild-type and Loa/Loa mouse brains. Time is shown in minutes. Scale bar = 10 μm. (B) Tracings of cell body position for six representative wild-
type neurons and six representative Loa/Loa neurons show a slower progression of somal movement in the Loa/Loa neurons. (C) Graph
depicting the average rates of leading process outgrowth and somal translocation (± standard deviation) for wild-type and Loa/Loa neurons (P <
0.0001 for somal translocation; n = 12 cells from at least three brains per genotype followed for at least 110 minutes).
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Page 6 of 13Axon extension is reduced in Loa/Loa neurons
Dynein and its regulatory factors, dynactin and LIS1,
have been implicated in axon elongation in rat brain
slices subjected to LIS1 RNAi and in cultured neurons
[7,35,36]. Oregon Green BAPTA staining could detect
clear trailing axons in a majority of radially migrating
neurons in wild-type mice (Figure 7A,C; 72.3%; n = 32
cells from three brain slices); however, axons were
detectable in fewer neurons in Loa/Loa slices (Figure
7B,C; 50.6%; n = 30 cells from three brain slices; P <
0.0001). Of the visible axons, 62.5% of the wild-type
axons could be followed for longer than 40 μmc o m -
pared with only 40.0% of the Loa/Loa axons (Figure
7D). We also observed a decrease in axon extension for
Loa/Loa neurons in vitro. We cultured neurons on lami-
nin for 2 or 3 days in vitro (DIV), then examined axonal
length. At DIV2, the average axon length of wild-type
neurons was 111 ± 23 μm compared with 54 ± 19 μm
for the Loa/Loa neurons (n = 57 and 53 neurons,
respectively; P < 0.0001), and by DIV3, the average axon
length of wild-type neurons was 125 ± 27 μm compared
with 89 ± 28 μm for the Loa/Loa neurons (n = 60 and
55 neurons, respectively; P < 0.0001) (Figure 8A,B).
Together with our earlier results [23], these results
reveal that dynein processivity is necessary for axon
elongation.
Loa/Loa mutant dynein can still bind its regulatory
proteins
We previously reported that the Loa mutation specifi-
cally affects the processivity of dynein due to apparent
miscoordination of the motor domains. We observed no
change in the association of the mutant dynein with iso-
lated neuronal membranes, further indicating that the
Figure 6 M i t o s i si sn o ts i g n i f i c a n t l ya f f e c t e di nt h eL o a / L o a
brains. (A) Wild-type and Loa/Loa brain sections immunostained
with PH3, which is expressed during mitosis. There was no
significant difference in the location of mitotic cells (either in
ventricular or abventricular regions), or in the number of mitotic
cells between the two genotypes, as depicted in the corresponding
graphs (average number of cells ± standard deviation). Scale bar =
100 μm. (B) BrdU pulse-labeling of wild-type and Loa/Loa embryos
reveals no significant difference between the number of BrdU-
labeled cells as shown in the images and graph (average number of
cells ± standard deviation). Scale bar = 100 μm.
Figure 7 Loa/Loa neurons display a defect in axon extension in
vivo. (A,B) Individual neurons from Oregon Green stained wild-type
(A) or Loa/Loa (B) brain sections with a visible axon (thin
arrowhead), or no visible axon (wide arrowhead). Neurons from
both the cortical plate (CP) and intermediate zone (IZ) were
analyzed. Scale bars = 20 μm. (C) Quantification of the percentage
of wild-type or Loa/Loa neurons with a visible axon. Only neurons
with visible leading processes were scored for an axon, or lack
thereof. Error bars represent the standard deviation. (D)
Quantification of the percentage of wild-type and Loa/Loa axons
that were shorter or longer than 40 μm.
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Page 7 of 13physiological effects of Loa could be accounted for by
altered mechanochemical activity alone [23]. However,
because the cytoplasmic dynein regulators NudE, LIS1,
and dynactin are also associated with brain develop-
ment, we tested the mutant dynein further for its ability
to interact with these factors. We performed pull-downs
with purified proteins rather than immunoprecipitations
with a dynein intermediate chain antibody, which might
interfere with these interactions. Pull-downs from brain
cytosol with recombinant glutathione S-transferase
(GST NudE revealed no difference in the associated
dynein or LIS1 between wild-type and Loa/Loa mutants
(Figure 9A,C; 66.2 ± 8.8% and 57.7 ± 9.1% of heavy
chain in the NudE pellet, respectively; P = 0.310). We
similarly tested the GST-tagged CC1 fragment from the
dynactin subunit p150
Glued, which interacts with the
dynein intermediate chain [37,38]. Comparable levels of
wild-type and Loa/Loa dynein were again found in the
CC1 pull-downs (Figure 9B,C; 45.3 ± 2.2% and 40.7 ±
10.7% of heavy chain in the pellet, respectively; P =
0.506). Therefore, the developmental defects we observe
in the Loa/Loa mice likely reflect intrinsic abnormalities
in the mutant dynein.
Discussion
We find that Loa mutant mice exhibit defects in cortical
and hippocampal development. Using live cell imaging
techniques, we found direct evidence for a migration
delay of bipolar neurons. Our results further indicate
that this effect is not associated with defects in dynein
interactions with LIS, NudE, or dynactin, and is there-
fore likely to result directly from the inherent mechano-
chemical defects caused by the Loa mutation [23].
The abnormal cortical lamination we observe in the
Loa/Loa mouse brain is similar to that seen in LIS1
compound heterozygous mutant mice [5,9]. LIS1 mice
exhibit severe disorganization of pyramidal cells in the
CA1, CA2, and CA3 regions, as well as a reduced den-
sity of granule cells in the dentate gyrus [9,39]. We
observe a clear delay in the migration of granule neu-
rons in the Loa/Loa mouse to form the dentate gyrus.
Although the formation of the dentate gyrus has not
been examined in the LIS1 mice, a delay in granule cell
migration could provide a potential explanation for the
diminished size of the dentate gyrus in these mice.
We detected a decrease in axon extension in Loa/Loa
neurons both in vivo and in vitro, as well as a decrease
in axon length. Dynein as well as LIS1 are necessary for
the reorganization and extension of the growth cone
during axonogenesis [7,35,36]. These proteins are
required to help microtubules extending into the per-
ipheral zone of the growth cone resist retrograde actin
flow [36]. A Loa mutant dynein detaches from microtu-
bules about twice as frequently as the wild-type motor
protein [23]. Therefore, microtubule penetration into
the peripheral zone could be compromised, providing
an explanation for altered axon elongation.
Altered expression of LIS, cytoplasmic dynein, and
NudE have each been found to affect mitotic index in
the developing brain [6,7,40]. These effects reflect direct
roles for these proteins in mitosis [31,41,42]. Further-
more, LIS1 and cytoplasmic dynein RNAi interfere with
apical migration of radial glial nuclei to the ventricular
surface, which has been found to be essential for mitotic
entry [7,43]. The similarity in mitotic index between
Loa/Loa and wild-type mouse brains suggests that any
effect on mitotic entry or progression must be relatively
minor, though further live analysis of mitosis might still
reveal altered mitotic behavior.
The current study indicates that the Loa mutation
affects neuronal migration in a similar manner as reduced
LIS1 expression [5,7,9]. However, the Loa mutation affects
dynein processivity [23], whereas LIS1 contributes to
Figure 8 Loa/Loa neurons exhibit a defect in axon extension in
vitro. (A) Neurons were cultured from wild-type and Loa/Loa brains
and grown for 2 or 3 days in vitro (DIV). Scale bars = 20 μm. (B)
Graph displaying the average length of an axon (± standard
deviation) from wild-type or Loa/Loa DIV2 or DIV3 neurons. An axon
is defined here as one process that is at least 40 μm long and twice
as long as the other processes.
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Page 8 of 13Figure 9 Loa/Loa dynein can still bind its regulatory partners. (A) GST-NudE pull-down assay from wild-type and Loa/Loa brain lysate. Input
is 30% of total. Immunoblot reveals that protein is not pulled down by beads alone (BA), but similar amounts of both wild-type (+/+) and Loa/
Loa (L/L) dynein (as shown by immunoblotting for dynein heavy chain and dynein intermediate chain) along with LIS1, are pulled down by GST-
NudE. HC, heavy chain; IC, intermediate chain. (B) GST-CC1 pull-down assay from wild-type and Loa/Loa brain lysate. Input is 30% of total.
Immunoblot reveals that dynein is not pulled down by beads alone (BA), but similar amounts of both wild-type (+/+) and Loa/Loa (L/L) dynein
(as shown by immunoblotting for dynein heavy chain and dynein intermediate chain) are pulled down by GST-CC1. A higher exposure blot
reveals the GST-CC1 band below the IC band. (C) Graph depicting the average percentage of wild-type or Loa/Loa dynein heavy chain (±
standard deviation) that is pulled into the pellet by either GST-NudE or GST-CC1 (n = 3 experiments per genotype).
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Page 9 of 13dynein force production [44]. Our results indicate, there-
fore, that different defects in dynein function can lead to a
common developmental outcome. The mechanical basis
for this result is uncertain, but is likely a consequence of
the coordinate behavior of multiple dynein molecules dur-
ing high load functions. In in vitro studies, LIS1 was found
to convert cytoplasmic dynein to a persistent force-produ-
cing state, though the level of force generation by indivi-
dual dynein molecules was unaffected. However, force
generation by multiple motors is summated, and this effect
was further enhanced by LIS1 as revealed in in vitro laser
trap bead assays and in computational simulations [44].
Thus, LIS1 appears to be ideally suited for a role in high
load functions such as nuclear transport [12,44]. The Loa
mutation, in contrast, had a clear effect on motor proces-
sivity [23]. How the Loa mutation might affect transport
of high load structures is uncertain, but could also involve
coordination of multiple dynein molecules. The Loa muta-
tion results not only in decreased single molecule proces-
sivity in vitro, but also in decreased run-lengths for
lysosomes/late endosomes in vivo, which are thought to be
driven by an average of approximately five to seven
dyneins [23,45,46]. Computational modeling indicates
that, although cargo run length increases with motor
number, the Loa processivity defect extends to the multi-
motor condition [23]. Thus, defects in neuronal migration
could conceivably be explained by a reduction in run
length during nuclear transport. We reason, however, that
Loa should also affect aggregate force production by mul-
tiple motors, which is a reflection of the number of indivi-
dual motors simultaneously ‘engaged’ with microtubules
at any given time. This value should be reduced for Loa as
a simple consequence of its increased microtubule detach-
ment rate. Thus, the defect in neuronal migration we
o b s e r v ei nt h eL o a / L o am o u s ecould result from shorter
nuclear run lengths, decreased force, or both. The pro-
longed state of somal distortion we observe during neuro-
nal migration in the Loa/Loa neurons could be indicative,
in particular, of a reduction in nuclear translocation forces,
but further work will be needed to directly determine the
effects of the Loa mutation at the multiple motor level.
The defects we observe in the mutant neurons may
explain the perilethality of the Loa/Loa mice. The Loa
homozygotes die within 24 hours of birth due to an
inability to move their mouths, and therefore feed. A 2-
day delay in the migration of facial motor neurons to
their destination may be responsible for this facial
paralysis. Correspondingly, a delay in axon extension
could also contribute to facial paralysis due to a lack of
muscle innervation.
Conclusions
Our results reveal a clear effect of the Loa mutation on
neuronal migration, in addition to its previously
reported effects on retrograde vesicular transport and
on motor and sensory neuron viability. Our observations
establish the utility of the Loa mouse as a hypomorphic
dynein mutant model for the investigation of not only
neurodegeneration but also general cytoplasmic dynein
function.
Materials and methods
Animals
Mice were housed in standard cages on a 12:12 light:
dark schedule at 25°C. All experimental research was
performed according to the guidelines of the Institu-
tional Animal Care and Use Committee (IACUC). All
experimental analyses were performed on mutant ani-
mals with littermate-matched controls.
Immunohistochemistry
Brains were fixed in 4% paraformaldehyde for 24 hours
after extraction, then transferred to phosphate-buffered
saline (PBS) until sectioning. Brains were sectioned on a
Vibrotome (Leica VT 1200S) into 50-μm thick slices.
For staining with primary antibodies, slices were blocked
at room temperature for 1 hour in PBS with 10% don-
key serum and 1% Triton X-100. For antibodies requir-
ing antigen retrieval (such as Foxp2), slices were boiled
in 10 mM sodium citrate buffer (pH 6), then cooled
back to room temperature before blocking. Primary
antibodies were applied overnight at 4°C in PBS with 1%
donkey serum and 0.1% Triton-X-100 at the following
dilutions: anti-ctip2, 1:500 (rat; Abcam, Cambridge, MA,
USA); anti-foxp2, 1:200 (rabbit; Abcam); PH3, 1:500
(rabbit; Millipore, Billerica, MA, USA); Prox1, 1:500
(rabbit; Abcam); Pax6, 1:200 (rabbit; Covance, Princeton,
NJ, USA); and TujI, 1:500 (mouse; Covance). Slices were
then washed in PBS and incubated with Cy2, Cy3, or
Cy5 secondary antibodies (1:1,000; Jackson ImmunoRe-
search Laboratories, West Grove, PA, USA). Sections
were mounted onto slides using VECTASHIELD Hard-
Set Mounting Medium with DAPI (VectorLabs, Burlin-
game, CA, USA), then imaged on an Olympus IX81
inverted microscope. At least three brains per genotype
were analyzed for each experiment.
BrdU labeling and analysis
For the BrdU birthdating assay in Figure 2, pregnant
mice were injected intraperitoneally with BrdU at 100
μg/g of body weight at either E16 or E18. The BrdU-
labeled females were left to give birth and their offspring
were sacrificed on P0. BrdU-positive cells in the cerebral
cortex were detected by immunostaining with an anti-
BrdU antibody (1:200, rat; Abcam). This antibody
required pre-treatment with 2N HCl for 15 minutes at
37°C prior to blocking. Staining was performed as
described above. To analyze the BrdU-positive neurons
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brain section was divided into six equal regions, and the
relative density and distribution of the BrdU-stained
neurons in each region was plotted.
For the BrdU pulse-chase experiment in Figure 5B,
pregnant mice were injected intraperitoneally with BrdU
at 100 μg/g of body weight at E16. The mice were then
sacrificed 2 hours after the injection to analyze the
number of BrdU pulse-labeled cells at the ventricular
surface in Loa/Loa and wild-type embryonic brains.
In utero electroporation
Plasmids were transfected using intraventricular injec-
tion followed by in utero electroporation as previously
described [25]. Briefly, 1 to 2 μl of GFP cDNA (concen-
t r a t i o no f1t o3μg/μl) were injected into the ventricle
of embryonic brains at E15. A pair of copper alloy oval
plates attached to the electroporation generator (Har-
vard Apparatus, Holliston, MA, USA) transmitted five
electric pulses at 40 V for 50 milliseconds at 1 second
intervals through the uterine wall. The embryos were
then sacrificed 3, 4, or 5 days later and their brains were
prepared as described above. The number of GFP-
labeled neurons at the ventricular zone, subventricular/
intermediate zone, and cortical plate was plotted for
Loa/Loa and wild-type littermates to assess the progres-
sion of neuronal migration from the ventricular surface.
Organotypic slice cultures and live cell imaging
These experiments were performed using a modified
procedure of previously described methods [28,47].
Briefly, E16 brains were collected and sectioned coron-
ally on a vibratome (Leica), then placed in a 50-mm
MatTek dish (MatTek Corporation, Ashland, MA,
USA) containing imaging medium (F12/MEM medium
with 10% fetal bovine serum and 1 × penicillin/strepto-
mycin (Invitrogen, Carlsbad, CA, USA) with 10 μg/ml
of Oregon Green BAPTA-1 488 AM (Invitrogen).
Slices were then incubated for 1 hour at 37°C with 5%
CO2. After the incubation, the slices were washed in
warmed PBS, then covered with a thin layer of Matri-
gel (BD Biosciences, San Diego, CA, USA) diluted 70 ×
in imaging medium, then incubated again for 30 min-
utes. The dish was then imaged in 1 ml of additional
imaging media with 10 mM Hepes at 37°C with 5%
CO2 on an Olympus IX81 inverted microscope. Images
were captured every 10 minutes for 3 to 5 hours using
an Hamamatsu ORCA-R2 CCD camera and Meta-
morph software (Molecular Devices, Sunnyvale, CA,
USA. The speed of migration and length of axon were
analyzed with Metamorph software. The position of
the soma center was measured in each image and dis-
placement of the soma was defined by the difference
in location of the center between consecutive frames.
Therefore, the somal speed is described here as the
displacement per unit time. The length of the axon
was defined as the distance from the basal end of the
soma to the tip of the process. Live cell imaging
experiments and axon length measurements were per-
formed on three brains per genotype.
Biochemical assays
Whole brain lysates from P0 wild-type and Loa/Loa
mouse pups were used for the NudE and CC1 pull-
downs. For each experiment, the lysate was first pre-
cleared with glutathione agarose 4B (USB Corporation,
Cleveland, OH, USA) in order to prevent non-specific
binding in the real assay. The beads were then spun
down, and the pre-cleared lysate was used for the pull-
downs. The pull-down solution contained the brain
lysate, phosphate-glutamate buffer (10 mM sodium
phosphate, 100 mM sodium glutamate, pH 7.0 with 1
mM MgSO4,1m ME D T A ,1m MD T T ,a n d0 . 2 %N P -
40) up to 350 μl and either beads alone, 1 μg/μlG S T -
NudE [44] or 1 μg/μl GST-CC1 [37,38]. The solutions
rotated at 4°C for 2 hours, then the beads were spun
down to separate the supernatants and pellets. The
supernatants and pellets from each pull-down (beads
alone, NudE, or CC1) were collected and analyzed by
SDS-PAGE and western blot probing for dynein heavy
chain (rabbit, 1:500) [48] and dynein intermediate
chain (mouse, 1:1500; clone 74.1 provided by K Pfister,
University of Virginia, Charlottesville, VA, USA). In
the case of the NudE pull-down, we also probed for
LIS1 (mouse, 1:1500; clone 338, Sigma, St. Louis, MO,
USA).
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